Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Shots - Health News
7:03 am
Sat August 2, 2014

Why Treating Ebola With An Experimental Serum Might Help

In 1995, amid an Ebola outbreak, Zairian Red Cross personnel picked up sick people and bodies left on the streets of Kikwit, 250 miles from the capital Kinshasa.
Jean-Marc Bouju AP

Originally published on Mon August 25, 2014 11:23 am

Last week we learned that two Americans working in Liberia for a medical charity, Samaritan's Purse, were among those who had contracted Ebola. When their symptoms took a turn for the worse, the organization announced that the two were going to get experimental treatments. One was going to get a blood transfusion from a 14-year-old boy who recovered from the disease, the organization said; the other was to get an "experimental serum." What's that?

Read more
Shots - Health News
6:34 pm
Fri July 11, 2014

Feds Tighten Lab Security After Anthrax, Bird Flu Blunders

Particles of H5N1 virus — a particularly dangerous type of bird flu that can infect people — attack lung cells.
Chris Bjornberg Science Source

Originally published on Fri July 11, 2014 8:21 pm

In the course of trying to understand a laboratory accident involving anthrax, officials at the Centers for Disease Control and Prevention stumbled upon another major blunder — involving a deadly flu virus.

Read more
Business
4:11 pm
Fri July 11, 2014

Declining Domestic Sales Speed Talks For Tobacco Mega-Merger

Originally published on Sun July 13, 2014 1:03 am

Transcript

MELISSA BLOCK, HOST:

From NPR News, this is ALL THINGS CONSIDERED. I'm Melissa Block. The U.S. tobacco industry could be in for a shakeup. Reynolds American, the maker of cigarette brands such as Camel and Pall Mall, confirmed today that it's in talks to buy its smaller rival, Lorillard. As NPR's Yuki Noguchi reports, the potential merger comes as the industry feels the pinch of declining sales.

Read more
Shots - Health News
3:32 am
Wed July 9, 2014

Like All Animals, We Need Stress. Just Not Too Much

Daniel Horowitz for NPR

Originally published on Thu July 10, 2014 12:09 pm

Ask somebody about stress, and you're likely to hear an outpouring about all the bad things that cause it — and the bad things that result. But if you ask a biologist, you'll hear that stress can be good.

In fact, it's essential.

Read more
Shots - Health News
1:52 pm
Tue July 8, 2014

Smallpox Virus Found In Unsecured NIH Lab

Not something you'd want to find: Smallpox viruses infect a cell.
Science Source

Originally published on Thu July 10, 2014 12:10 pm

Scientists cleaning out an old laboratory on the National Institutes of Health campus in Bethesda, Md., last week came across a startling discovery: vials labeled "variola" — in other words, smallpox.

Under international convention, there are supposed to be only two stashes of this deadly virus: one at the federal Centers for Disease Control and Prevention in Atlanta, and another at a similar facility in Russia.

The CDC swooped in to collect the vials and carted them off to a secure lab at its Atlanta headquarters.

Read more
Shots - Health News
5:14 pm
Thu June 5, 2014

Quick DNA Tests Crack Medical Mysteries Otherwise Missed

Doctors used a rapid DNA test to identify a Wisconsin teen's unusual infection with Leptospira bacteria (yellow), which are common in the tropics.
CDC/Rob Weyant

Originally published on Sat June 7, 2014 9:07 am

Researchers are developing a radical way to diagnose infectious diseases. Instead of guessing what a patient might have, and ordering one test after another, this new technology starts with no assumptions.

The technology starts with a sample of blood or spinal fluid from an infected person and searches through all the DNA in it, looking for sequences that came from a virus, a bacterium, a fungus or even a parasite.

Read more
Shots - Health News
2:28 pm
Thu May 29, 2014

Measles Hits Amish Communities, And U.S. Cases Reach 20-Year High

Measles was brought to Ohio's Amish communities by people returning from mission trips to the Philippines.
Chuck Crow The Plain Dealer/Landov

Originally published on Thu May 29, 2014 6:34 pm

Members of Amish communities in Ohio traveled to the Philippines for heartfelt reasons: They were there on service projects to help less fortunate people. Unfortunately, they came home with unwelcome hitchhikers: measles viruses.

Those travelers hadn't been vaccinated against this highly contagious disease, the Centers for Disease Control and Prevention said Thursday. As a result, they have triggered an outbreak of more than 130 cases, primarily among their unvaccinated friends and relatives in Amish communities.

Read more
Shots - Health News
2:21 pm
Thu May 22, 2014

Experimental Malaria Vaccine Blocks The Bad Guy's Exit

Red blood cells infected with the Plasmodium falciparum parasite. Plasmodium is the parasite that triggers malaria in people.
Gary D. Gaugler Science Source

Originally published on Thu May 22, 2014 6:46 pm

For the first time in decades, researchers trying to develop a vaccine for malaria have discovered a new target they can use to attack this deadly and common parasite.

Finding a target for attack is a far cry from having a vaccine. And the history of malaria vaccines is littered with hopeful ideas that didn't pan out. Still, researchers in the field welcome this fresh approach.

Read more
Shots - Health News
2:18 pm
Thu May 15, 2014

Medicine Needs More Research On Female Animals, NIH Says

Sex can matter, whether you're looking at drug side effects, the response to treatment, or the progression of a disease.
iStockphoto

Originally published on Thu May 15, 2014 3:22 pm

Many potential new drugs look like they could be big winners — at least when judged by how well they work in mice or other lab animals. Over the years, there have been a number of promising cancer "cures," possible Alzheimer's treatments, and candidate drugs for holding back the ravages of various degenerative diseases.

But, time after time, these great promises fade away once the potential treatments are tried in people. There are lots of reasons for that. Humans aren't rodents, for starters.

Read more
Shots - Health News
12:44 pm
Thu May 8, 2014

If Polar Bears Can Eat A Ton Of Fat And Be Healthy, Why Can't We?

Lots of swimming in icy seas may have helped bears evolve to eat a high-fat diet yet remain healthy.
Sebastien Bozon AFP/Getty Images

Originally published on Thu May 8, 2014 6:20 pm

If you were a bear and wanted to make a go of it in the frozen North (think polar bear, of course), what would you need to survive?

White fur would help, to help you sneak up on prey. Also plenty of body fat to stay warm. And you'd need great stamina to swim many miles from one ice floe to the next.

And there's another important trait, researchers reported Thursday: Polar bears have genes that help them live on a diet that's overloaded with fat — without suffering the sorts of human diseases that typically come with a diet of that sort.

Read more

Pages